{"id":"W2113556993","doi":"10.1056/nejmoa0910812","title":"Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1578,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; University of Calgary; McGill University; Alberta Health Services","funders":"","keywords":"Fidaxomicin; Medicine; Vancomycin; Clostridium difficile; Internal medicine; Metronidazole; Diarrhea; Gastroenterology; Clinical endpoint; Surgery; Giardia; Clinical trial; Antibiotics; Microbiology; Staphylococcus aureus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08994094679645827,"score_gpt":0.3276193828881358,"score_spread":0.2376784360916775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}